🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study evaluates TL-895, a potent, orally-available and highly selectiv...
Status
Unknown
Location
University of Colorado - Aurora Cancer Center
Start Date
2020-10-22
Trial ID
NCT04655118
This study evaluates either KRT-232 or TL-895 in treatment naïve patients w...
Status
Unknown
Location
Innovative Clinical Research Institute
Start Date
2021-04-13
Trial ID
NCT04878003
This study evaluates TL-895, a potent, orally available and highly selectiv...
Status
Unknown
Location
Keck School of Medicine
Start Date
2021-03-31
Trial ID
NCT04669067
This study evaluates KRT-232 in Combination With TL-895 for the Treatment o...
Status
Unknown
Location
University of Alabama at Birmingham School of Medicine, Division of Hematology and Oncology
Start Date
2020-11-17
Trial ID
NCT04640532
The purpose of this research study is to determine the safety and tolerabil...
Status
Unknown
Location
Ohio State University Wexner Medical Center
Start Date
2016-08-26
Trial ID
NCT02825836
Treatments Being Tested
This study evaluates TL-895, a tyrosine kinase inhibitor (TKI). This is a s...
Status
Completed
Location
Georgia Cancer Center
Start Date
2020-07-09
Trial ID
NCT04419623
Treatments Being Tested
This study evaluates TL-895, a potent, orally-available and highly selectiv...
Status
Recruiting
Location
University of Alabama at Birmingham
Start Date
2022-06-09
Trial ID
NCT05280509
Treatments Being Tested